VERTEX PHARMACEUTICALS INC / MA Deferred Tax Liabilities, Property, Plant and Equipment
VERTEX PHARMACEUTICALS INC / MA (VRTX) had Deferred Tax Liabilities, Property, Plant and Equipment of $110.80 million as of 2024-12-31, per its 10-K filed 2025-02-13.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment · last filed 2025-02-13
- 2024-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $110.80M.
- 2023-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $145.10M.
- 2022-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $139.80M.
- 2021-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $118.20M.
| Period end | Deferred Tax Liabilities, Property, Plant and Equipment | Deferred Tax Liabilities, Property, Plant and Equipment as first filed |
|---|---|---|
| 2024-12-31 | $110.80M 10-K · filed 2025-02-13 | |
| 2023-12-31 | $145.10M 10-K · filed 2025-02-13 | |
| 2022-12-31 | $139.80M 10-K · filed 2024-02-15 | |
| 2021-12-31 | $118.20M 10-K · filed 2023-02-10 | |
| 2020-12-31 | $117.00M 10-K · filed 2022-02-09 | $116.95M 10-K · filed 2021-02-11 |
| 2019-12-31 | $101.23M 10-K · filed 2021-02-11 | |
| 2018-12-31 | $128.41M 10-K · filed 2020-02-13 | |
| 2017-12-31 | $101.02M 10-K · filed 2019-02-13 | |
| 2016-12-31 | $169.09M 10-K · filed 2018-02-15 | |
| 2015-12-31 | $175.42M 10-K · filed 2017-02-23 | |
| 2014-12-31 | $158.99M 10-K · filed 2016-02-16 | |
| 2013-12-31 | $134.10M 10-K · filed 2015-02-13 | |
| 2012-12-31 | $0.00 10-K · filed 2014-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |